ѻýҕl

<ѻýҕl class="page-title">Meeting Coverage

IGCS Video Pearls

<ѻýҕl class="page-description">Video Pearls from the International Gynecologic Cancer Society
KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer

Domenica Lorusso details the importance of modern radiotherapy in this regimen

image
<ѻýҕl class="section_title">Latest IGCS Video Pearls Meeting Coverage
Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer

Next step for avutometinib/defactinib combination is going forward with phase III trial

December 5, 2023
Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer

Response rates of 14% alone and 18% in combination with checkpoint inhibitor

November 28, 2023
Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial

"But I don't think it closes the door" on this class of drugs, says Ritu Salani, MD

November 21, 2023
<ѻýҕl class="section_title"> Latest OB/Gyn Meeting Coverage